...
首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >A comparative study of efficacy and safety of intramuscular carboprost and intravaginal misoprostol for cervical priming prior to first trimester surgical abortion
【24h】

A comparative study of efficacy and safety of intramuscular carboprost and intravaginal misoprostol for cervical priming prior to first trimester surgical abortion

机译:肌内卡泊前列素和阴道米索前列醇在早孕手术流产前宫颈启动的疗效和安全性比较研究

获取原文

摘要

Background: MTP Act no 34 of 1971 has been defined as Legal termination of pregnancy before the age of viability of fetus that is 20 weeks of gestation. There is a need to find a medical agent which can help in the process of abortion by speeding it up, with minimal side effects. The objective of this study was to compare the efficacy of I.M carboprost and intravaginal Misoprostol and to evaluate the safety profile of I.M carboprost and Intravaginal Misoprostol. To compare the cervical dilatation caused by I.M carboprost and intravaginal Misoprostol and to compare the blood loss and adverse effects of I.M carboprost and Intravaginal Misoprostol. Methods: Prospective randomized experimental study including pregnant women up to 12 weeks of gestation opting for M.T.P. Study conducted on 200 patients selected from patients admitted in MGM Medical College and M.Y. Hospital, Indore and Kalyanmal Hospital, Indore during the period July 2014 to March 2015. They were randomly divided into 2 groups. Group A who received intramuscular injection of 250 mcg of caboprost or Group B,which received 400 mcg of vaginal Misoprostol 4 hours prior to suction evacuation. Results: Intravaginal misoprostol achieves better cervical dilatation compared I.M carboprost which is statistically significant. Misoprostol is associated with higher blood loss as compared to I.M carboprost which is associated with nausea/vomiting & more likelihood of loose stools and abdominal cramps which is proved statistically. Conclusions: Intravaginal misoprostol is associated with higher blood loss as compared to I.M carboprost which is significant but intravaginal misoprostol achieves more cervical dilatation and causes less adverse events than I.M carboprost which is statistically more significant and therefore intravaginal misoprostol is the drug of choice for cervical priming prior to surgical abortion in terms of both efficacy and safety.
机译:背景:1971年第34号MTP法案已被定义为在胎儿存活20周之前合法终止妊娠。需要找到一种药物,它可以通过加快流产的过程而对流产产生帮助,同时具有最小的副作用。这项研究的目的是比较卡莫前列素和阴道内米索前列醇的疗效,并评估卡莫前列素和阴道内米索前列醇的安全性。比较I.M卡波前列素和阴道内米索前列醇引起的宫颈扩张,并比较I.M卡波前列素和阴道内米索前列醇的失血量和不良反应。方法:前瞻性随机实验研究包括怀孕至12周的孕妇选择M.T.P.研究对象是200名从MGM医学院和M.Y.于2014年7月至2015年3月,在Indore的Indore医院和Kalyanmal医院。将他们随机分为2组。 A组肌肉注射250 mcg卡波前列素或B组在抽气前4小时接受400 mcg阴道米索前列醇。结果:与I.M卡波前列素相比,阴道内米索前列醇可实现更好的宫颈扩张效果,这在统计学上具有重要意义。与I.M卡波前列素相比,米索前列醇的出血量更高,这与恶心/呕吐和大便稀少和腹部绞痛的可能性更高有关,这在统计学上得到了证明。结论:与IM卡泊前列醇相比,阴道内米索前列醇具有更高的失血量,这是显着的,但与IM卡泊前列素相比,阴道内米索前列醇可实现更多的宫颈扩张,并引起较少的不良事件,因此IM卡波前列素具有更大的统计学意义,因此阴道内米索前列醇是宫颈致敏剂的首选药物就疗效和安全性而言,在手术流产之前。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号